Huber Needles Market will generate new growth opportunities 2021-2028 | Baxter International Inc., B. Braun Medical Inc., Smiths Medical, NIPRO Medical Corporation

Straight Huber needles and curved Huber needles are the two varieties of Huber needles available. Straight Huber needles are used for brief access and have a 90 degree angle. Curved Huber needles are used for long lasting access and have a 90 degree angle. This needles are used in a variety of purposes, including blood transfusion, dialysis, chemotherapy and other procedures. Huber needles are a good substitute for other infusion devices.

Statistics:

The global Huber needles market is expected to account around US$ 66.1 Mn in terms of value and over 51,270,030 Units in terms of volume by the end of 2027.

Global Huber Needles Market: Drivers

Government laws restricting the use of safety needles are in order to discourage hospital-acquired diseases including HIV, Hepatitis C, and Hepatitis B, are expected to drive growth of the global Huber needles market during the forecast period. For instance, the Needlestick Safety and Prevention Act was passed in the U.S. in 2000. The act focuses on supplying nurses and medical personnel with knowledge on extra precautions to take before using needles in order to avoid workplace exposure to bloodborne pathogens.

To Get more Business Statergies Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/3648

Global Huber Needles Market: Restraints

Product recalls due to technical issues with Huber needles are expected to hamper growth of the global Huber needles market over the forecast period. Huber needle and protective devices are made from a variety of medical-grade materials. Moreover, in the past, it was thought that using Huber needles could result in silicon pollution. However, businesses were required to recall their goods in quantity in order to prevent additional contamination.

Key Takeaways:

The Curved Huber Needles segment in the global Huber needles market was accounted around US$ 32.3 Mn in 2019 and is estimated to reach over US$ 53.4 Mn by 2027 at a CAGR around 6.5% over the forecast period. Rising prevalence and growing number of cancer cases is expected to propel growth of the global Huber needles market over the forecast period.

The IV Cancer Application segment held a significant position in the global Huber needles market in 2019, accounting over 41.7% share in terms of value, followed by dialysis, respectively. Rising demand and growing adoption of expansion strategies by major players in the market to broaden their product range and geographical positioning, are expected to propel growth of the global Huber needles market.

To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/3648

Market Trends

Rising incidences of end-stage renal disorders is expected to drive growth of the global Huber needles market over the forecast period. For instance, according to November 2019 data of National Center for Biotechnology Information, end-stage renal failure is increasing at a steady rate of around 20,000 cases per year.

Key players in the global Huber needles market are concentrating on various marketing initiatives to broaden their customer base. For instance, in February 2020, Baxter International Inc. presented at the 9th Annual SVB Leerink Global Healthcare Conference in New York, N.Y.

Regulations

Europe

• European Union (EU) mandates the design and quality assurance test in order to maintain the safety guideline

• EU categorized Huber needle under Class III device, which requires EC verification and quality assurance for marketing and commercialization

Global Huber Needles Market: Competitive Landscape

Key players are dominating in the global Huber Needles market such as, B. Braun Medical Inc., Baxter International Inc., NIPRO Medical Corporation, Smiths Medical, C. R. Bard, Inc. and AngioDynamics, Inc.

Global Huber Needles Market: Key Developments

Key players in the global Huber needles market are concentrating on adoption of M&A initiatives to broaden their product range. For instance, in March 2018, Smiths Medical has implemented a new non-hospital infusion distribution platform that streamlines the buying, receiving, and supply of CADD infusion therapy products.

To Direct Purchase this Research Report – https://www.coherentmarketinsights.com/insight/buy-now/3648

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐒:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.